1.
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by Welsh, Paul
Diabetologia, 2018-05-04, Vol.61 (7), p.1581-1591
2.
Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential
by Zha, Dongqing
Endocrinology (Philadelphia), 2017-07-01, Vol.158 (7), p.2022-2034
3.
Protection from diabetes-induced atherosclerosis and renal disease by d-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mi...
by Menini, Stefano
Diabetologia, 2014-12-04, Vol.58 (4), p.845-853
4.
Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis
by He, F
Diabetologia, 2012-12-12, Vol.56 (3), p.457-466
5.
Biomarkers of diabetic nephropathy: A 2017 update
by Papadopoulou-Marketou, Nektaria
Critical reviews in clinical laboratory sciences, 2017-07-04, Vol.54 (5), p.326-342
6.
Circulating Fibroblast Growth Factor 21 Levels Predict Progressive Kidney Disease in Subjects With Type 2 Diabetes and Normoalbuminuria
by Lee, C. H
The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1368-1375
7.
Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with diabetes
by Schwandt, Anke
Journal of diabetes and its complications, 2017-09, Vol.31 (9), p.1376-1383
8.
Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus
by Liu, Jian-Jun
The journal of clinical endocrinology and metabolism, 2017-10-01, Vol.102 (10), p.3683-3691
9.
Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus
by Bakris, George L., MD
Mayo Clinic proceedings, 2011, Vol.86 (5), p.444-456
10.
Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?
by Sabanayagam, C
Diabetologia, 2009-04-22, Vol.52 (7), p.1279-1289
11.
Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy
by Titan, S.M
Journal of diabetes and its complications, 2012, Vol.26 (6), p.546-553
12.
Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease
by Eissa, Sanaa
Journal of diabetes and its complications, 2016, Vol.30 (8), p.1585-1592
13.
Ocular Surface Disease in Patients with Diabetic Peripheral Neuropathy
by DeMill, David L David L
British journal of ophthalmology, 2015-10-23, Vol.100 (7), p.924-928
14.
Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
by Hara, M
Diabetologia, 2012-08-02, Vol.55 (11), p.2913-2919
15.
Anti-Inflammatory Effect of Combined Sitagliptin and Vitamin D3 on Cytokines Profile in Patients with Type 2 Diabetes Mellitus
by Borzouei, Shiva
Journal of interferon & cytokine research, 2019-05-01, Vol.39 (5), p.293-301
16.
Variability in glycated albumin levels predicts the progression of diabetic nephropathy
by Park, Su Bin
Journal of diabetes and its complications, 2017, Vol.31 (6), p.1041-1046
17.
Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?
by Marshall, S. M
Diabetologia, 2012-06-14, Vol.55 (9), p.2301-2306
18.
Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
by Sato, Atsuhisa
Hypertension (Dallas, Tex. 1979), 2003-01, Vol.41 (1), p.64-68
19.
IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy
by Hjortebjerg, Rikke
The journal of clinical endocrinology and metabolism, 2015-08, Vol.100 (8), p.3032-3040
20.
Transforming growth factor-β1 in children with diabetic nephropathy
by Sawires, Happy
Pediatric nephrology (Berlin, West), 2018-08-22, Vol.34 (1), p.81-85
